Two Sigma Securities’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,226
Closed -$856K 2115
2025
Q4
$856K Buy
+5,226
New +$819K 0.12% 214
2025
Q2
Sell
-1,879
Closed -$239K 1986
2025
Q1
$239K Buy
+1,879
New +$289K 0.04% 740
2024
Q4
Sell
-10,644
Closed -$1.58M 2920
2024
Q3
$1.58M Buy
10,644
+7,706
+262% +$1.1M 0.03% 647
2024
Q2
$370K Buy
2,938
+447
+18% +$70.1K ﹤0.01% 1801
2024
Q1
$458K Buy
+2,491
New +$474K ﹤0.01% 1638
2023
Q4
Sell
-2,784
Closed -$433K 3483
2023
Q3
$443K Buy
+2,784
New +$455K ﹤0.01% 1627
2023
Q2
Sell
-2,930
Closed -$470K 3248
2023
Q1
$493K Buy
+2,930
New +$523K 0.01% 1267
2022
Q3
Sell
-1,478
Closed -$312K 3012
2022
Q2
$240K Buy
1,478
+184
+14% +$29.1K 0.01% 1498
2022
Q1
$243K Buy
1,294
+535
+70% +$102K 0.01% 1586
2021
Q4
$201K Buy
+759
New +$204K 0.01% 1087
2021
Q3
Sell
-1,465
Closed -$292K 1876
2021
Q2
$292K Buy
+1,465
New +$284K 0.01% 1002
2019
Q1
Sell
-3,967
Closed -$209K 2336
2018
Q4
$209K Buy
+3,967
New +$233K ﹤0.01% 1689

Other funds holding RGEN

Two Sigma Securities's RGEN Position: Q1 2026 in Review

Two Sigma Securities sold out of Repligen (RGEN) in Q1 2026, closing a stake of 5,226 shares — an estimated $856K sold.

Two Sigma Securities first reported a position in RGEN in Q4 2018 and held it in 12 quarters. The position peaked at $1.58M in Q3 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Two Sigma Securities reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 5,226 Repligen shares in Q1 2026, an estimated $856K.
  • Two Sigma Securities first reported a position in Repligen in Q4 2018 and held it in 12 quarters.
  • Two Sigma Securities's Repligen position peaked at $1.58M in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.